1st Quarter - Report — CEPHEID for CEPHEID (2016)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

CEPHEID

Client

CEPHEID

Income

—

Expenses

$42,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report (this page)	Aug 8, 2016	$42,000	Replaced
1st Quarter - Amendment	Aug 8, 2016	$29,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Lobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance, antimicrobial resistance/antibiotic stewardship), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight of clinical laboratory tests, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues, disease specific issues (multi-drug resistant tuberculosis, infection)

Lobbyist	Covered position, as disclosed
MICHELE M SCHOONMAKER	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); White House Office; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA)

Medicare/Medicaid MMM

Lobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues

Lobbyist	Covered position, as disclosed
MICHELE M SCHOONMAKER	—

Contacted: White House Office; SENATE; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Lobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues

Lobbyist	Covered position, as disclosed
MICHELE M SCHOONMAKER	—

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); White House Office; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS)

Science/Technology SCI

molecular diagnostic tests, infection control platforms, regulation of laboratory tests, reimbursement for laboratory tests. antimicrobial resistance/antibiotic stewardship

Lobbyist	Covered position, as disclosed
MICHELE M SCHOONMAKER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); White House Office; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.